Skip to content

EUROPHARMEDTECH: what changed

BE 0685.431.593NACE 72.101, Research and development on biotechnologyOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€69,941
2024 · -€53,223-€16,718
Equity
-€28,814
2024 · €41,127-€69,941
Cash
€194
2024 · €7,825-€7,630
Balance sheet total
€54,960
2024 · €93,699-€38,739

Largest movements

2024 to 2025
Assets
  • Deferred charges and accrued income -€18,133

    down €18,133 (-95.1%), from €19,063 to €930

  • Receivables within one year -€9,527

    down €9,527 (-16.4%), from €58,250 to €48,723

    of which Other amounts receivable: -€6,598

  • Cash -€7,630

    down €7,630 (-97.5%), from €7,825 to €194

    mainly Net result for the year (-€69,941) and Tax, wage and social debts (-€3,532)

  • Tangible fixed assets -€3,449

    down €3,449 (-40.3%), from €8,561 to €5,113

    of which Furniture and vehicles: -€3,025

Equity and liabilities
  • Profit (loss) carried forward -€69,941

    down €69,941, from €22,527 to -€47,414

  • Trade debts +€31,471

    new in 2025: €31,471

  • Other debts +€3,966

    up €3,966 (+13.6%), from €29,130 to €33,097

  • Tax, wage and social debts -€3,532

    down €3,532 (-19.8%), from €17,870 to €14,338

    of which Taxes: -€3,022

Income statement
  • Gross operating margin -€16,394

    down €16,394, from €10,453 to -€5,941

  • Financial charges -€2,566

    down €2,566 (-54.5%), from €4,710 to €2,144

  • Staff costs +€2,523

    up €2,523 (+4.6%), from €55,100 to €57,623

  • Financial income -€311

    down €311 (-84.4%), from €368 to €57

  • Other operating charges +€221

    up €221 (+43.7%), from €506 to €727

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 -€53,223
Gross operating margin -€16,394
Staff costs -€2,523
Depreciation +€156
Other operating charges -€221
Other operating items -€63
Financial income -€311
Financial charges +€2,566
Taxes +€73
Result 2025 -€69,941
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations -€6,990
Investment +€63
Financing -€704
Cash 2024 €7,825
Net result for the year -€69,941
Depreciation +€3,385
Receivables within one year +€9,527
Deferred charges and accrued income +€18,133
Trade debts +€31,471
Tax, wage and social debts -€3,532
Other debts +€3,966
Investment in fixed assets (net) +€63
Short-term financial debts -€704
Cash 2025 €194
brings cash intakes cash out
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €93,699 €54,960 -€38,739 -41.3%
Fixed assets 21/28 €8,561 €5,113 -€3,449 -40.3%
Tangible fixed assets 22/27 €8,561 €5,113 -€3,449 -40.3%
Plant, machinery and equipment 23 €1,854 €1,430 -€424 -22.9%
Furniture and vehicles 24 €6,708 €3,683 -€3,025 -45.1%
Current assets 29/58 €85,138 €49,847 -€35,291 -41.5%
Amounts receivable within one year 40/41 €58,250 €48,723 -€9,527 -16.4%
Trade receivables 40 €48,075 €45,145 -€2,930 -6.1%
Other amounts receivable 41 €10,176 €3,578 -€6,598 -64.8%
Cash at bank and in hand 54/58 €7,825 €194 -€7,630 -97.5%
Deferred charges and accrued income 490/1 €19,063 €930 -€18,133 -95.1%
Total equity and liabilities 10/49 €93,699 €54,960 -€38,739 -41.3%
Equity 10/15 €41,127 -€28,814 -€69,941
Contributions 10/11 €18,600 €18,600 = 0.0%
Profit (loss) carried forward 14 €22,527 -€47,414 -€69,941
Amounts payable 17/49 €52,572 €83,773 +€31,202 +59.4%
Amounts payable within one year 42/48 €48,372 €79,573 +€31,202 +64.5%
Financial debts 43 €1,372 €668 -€704 -51.3%
Credit institutions 430/8 €1,372 €668 -€704 -51.3%
Trade debts 44 - €31,471 +€31,471
Suppliers 440/4 - €31,471 +€31,471
Taxes, remuneration and social security 45 €17,870 €14,338 -€3,532 -19.8%
Taxes 450/3 €6,099 €3,077 -€3,022 -49.5%
Remuneration and social security 454/9 €11,771 €11,261 -€510 -4.3%
Other amounts payable 47/48 €29,130 €33,097 +€3,966 +13.6%
Accrued charges and deferred income 492/3 €4,200 €4,200 = 0.0%
Non-recurring operating income 76A €1,348 - -€1,348
Remuneration, social security and pensions 62 €55,100 €57,623 +€2,523 +4.6%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €3,541 €3,385 -€156 -4.4%
Other operating charges 640/8 €506 €727 +€221 +43.7%
Non-recurring operating charges 66A - €63 +€63
Gross operating margin 9900 €10,453 -€5,941 -€16,394
Operating profit (loss) 9901 -€48,694 -€67,740 -€19,046 -39.1%
Financial income 75/76B €368 €57 -€311 -84.4%
Recurring financial income 75 €368 €57 -€311 -84.4%
Financial charges 65/66B €4,710 €2,144 -€2,566 -54.5%
Recurring financial charges 65 €4,710 €2,144 -€2,566 -54.5%
Profit (loss) for the period before taxes 9903 -€53,036 -€69,827 -€16,791 -31.7%
Income taxes 67/77 €187 €114 -€73 -39.0%
Profit (loss) for the period 9904 -€53,223 -€69,941 -€16,718 -31.4%
Profit (loss) for the period to be appropriated 9905 -€53,223 -€69,941 -€16,718 -31.4%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

The filed figures and these assumptions give no positive value. The adjusted equity and the average result are both zero or negative.

Part of the calculation comes out below zero. A shareholding is never worth less than zero, so the floor is zero.

Adjusted equity -€28,814

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
-€28,814
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
-€28,814

Capitalised earnings

net result for the year (9904)
2025
-€69,941
excluding non-recurring income and charges
-€69,878
2024
-€53,223
excluding non-recurring income and charges
-€54,571
2023
€75,401
excluding non-recurring income and charges
€80,281
2022
€42,597
excluding non-recurring income and charges
€39,972
2021
€2,803
Average result, excluding non-recurring income and charges
-€14,723
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
not meaningful, as the average result is zero or negative

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 9 November 2026 via checked.be.